minister says there's roughly $4000.00 variants of the virus around the world scientists at oxford university in the u.k. are looking at how they can improve their jabs they've started the trial to see if it's possible to mix doses between pfizer and astra zeneca vaccines not in barbour is standing by at a hospital in london for us to tell us more about the banks in trials in the u.k. 1st to dorset jabari in tehran with our 1st consignment of vaccines has just landed so dosser when do they start using it. well we believe they will be rolled out as soon as possible and of course the prove people who will receive it 1st will be health care workers and front line workers in the country we have heard from officials who said that this is a very welcome news that the 1st shipment has finally landed in the country after months of attempts by iran to secure vaccines from various sources of course the iranian officials had said they would not purchase any vaccines made in the us or britain but they did end up purchasing $18000000.00 doses in total from countries such as china india and russia and we'v

trial was led by oxford university is a professor. who was who also co-author of the study welcome to day w. this sounds like a big step forward given that aspirin medication is widely available and inexpensive. yes i mean it was. quite fascinating that the study was suggestive of of a positive outcome would be inhaled medicines. and we are quite. pleased with that but obviously with the understanding that it was a small limited study and so last our results would be suggestive of that and we look forward to hearing from. investigators who are also looking in similar fashion similar medicines ok so as a small study we were able to identify what it was about these ozma medications that makes them so effective against common symptoms it's so studies already in the process so early on in the pandemic i'm from last year showed that in in i know the bullet tree the ass night inhaled medicines could reduce virus replication in the lung knighting said but this is experimental studies and our findings that actually chronic illnesses with resp

was led by oxford university is a professor mona battle who was who also coauthored the study welcome to day w. this sounds like a big step forward given that aspirin medication is widely available and inexpensive. yes i mean it was. quite fascinating that the study was suggestive of of a positive outcome with this inhaled medicines. and we are quite pleased with that but obviously with the understanding that it was a small limited study and so lost our results would be suggestive of that and we look forward to hearing from. investigators who are also looking in similar fashion similar medicines ok so as a small study we were able to identify what it was about v.a.'s ask my medications that makes them so effective against kawin sometimes it's so studies already in the process so early on in the pandemic i'm from last year showed that in the bowl that tree the ass night inhaled medicines could reduce by iris replication in the lung 9 and so but this is experimental studies and our findings that actually chronic illnesses with she mentioned such as asner and comic strip to common diseas

of the the local population but the government are now saying that they're going to work with oxford university in a world 1st trial they want over 800 volunteers ages more than 50 people who haven't had a job and they're going to give them a 1st dose of either the oxford astra zeneca the nation or the pfizer beyond take vaccination and then they'll get a 2nd one within 12 weeks that could be the same or it could be an alternative vaccination so they want to find out whether protection is actually worse the same or even better if you get a mixture of vaccines they're saying the other vaccines could be involved such as the norovirus in the yards and vaccines once very approved as well and the scientists in this study are hoping that it could give them clues as to how to fight better against those variants as well which of emerging not just here but in south africa and brazil a belgian court has convicted an iranian diplomat for attempted terrorism and sentenced him to 20 years in prison. was found guilty of plotting to bomb an opposition rally outside paris and $2183.00 of his accomplices june i

trial was led by oxford university as a professor mode but how the who was cold so co-author of the study welcome to day w this sounds like a big step forward given that asthma medication is widely available and inexpensive yes i mean it would sound. quite fascinating but the study was suggestive of a positive outcome would be inhaled medicines. and we are. quite. pleased with that but obviously with the understanding that it was a small limited study and so last our results would be suggestive of that and we look forward to hearing from. investigators who are also looking in shimla fashion similar medicines ok so as a small study we were able to identify what it was about viz assman medications that makes them so effective against covered sometimes. so studies already in the process so early on in the pandemic i'm from last year showed that in him and though the bullet tree the ass my inhale medicines could reduce virus replication in the lung 9 ng so but this is experimental studies and our findings that actually chronic illnesses with respect she mentioned such as asner and chronic str

in washington becoming the national poet in the federal city, which was just published by the oxford university press and it's available for 29.95 in hardback. welcome ken good to see you. so it's wonderful to see you too katarina. yeah, it's great to be here with you. so can you tell us more about the idea? for how this book came to you? how did it start as a project for you? well, like many whitman scholars, i've been fascinated by whitman's relationship to a variety of cities. he's probably most famously associated with the new york area, long island, new york city, but he also spent some formative months in new orleans as you know, and others know and then a decade in washington dc the time period that i focused on and then at the end of his life, of course he was in the philadelphia and camden new jersey area. so those are the four big places for whitman and it seemed to me that the washington decade had been you know studied but in some ways strangely neglected, it hadn't really been given its due and i started to gravitate toward that i did a digital project on civil war washington that'

1000 vaccines for the 1st and 2nd doses will show strong efficacy the trials will be led by oxford university and run by the national immunization schedule of valuation consortium now the 1st trials it will involve more than $800.00 volunteers above the age of 50 and test the effectiveness of 4 combinations of 1st and 2nd shots of the astra zeneca oxford university vaccine and the fires are biotech vaccine results of the trials are not actually expected into.

astrazeneca and oxford university say they plan to have a �*next generation�* covid vaccine ready foral editor fergus walsh reports. the scientists at oxford who created the astrazeneca vaccine are continually monitoring how coronavirus is evolving. the current vaccine is thought to give good protection against new variants, but they�*re working on tweaking the jab to make it future—proof. the scientist who�*s leading the research says it�*s relatively simple to redesign the vaccine. it�*s not difficult to put a different antigenic insert into the vaccine. so, we don�*t want to panic and say that we must have a new version of the vaccine now but on the other hand we are getting prepared, so that if it turns out we do need a new version, we will be ready to start using it. it'sjust going to be a sharp scratch, ok? those on the oxford vaccine trials were shown to have 76% protection from a single dose, which lasted three months, rising to 82% protection, with the second shot. you�*ll be doing swabs every week at home. it�*s also the first time a covid vaccine has been shown to reduce tr

an oxford university spokesman said that no personal data agency gchq was investigating.anoramic rover on mars. the panorama shows the rim of the jezero crater, where the rover touched down last week and the cliff face of an ancient river delta in the distance. it was taken by rotating the rover�*s mast 360 degrees. nasa says the panorama is composed of 142 individual images stitched together on earth. the former coach of the us women's gymnastics team, john geddert, has killed himself, hours after being charged with human trafficking and criminal sexual conduct. the body ofjohn geddert was found after he failed to surrender himself at a sheriff's office. the charges against the coach involved a number of young women, including two counts of sexual assault on a young girl when she was aged thirteen and later sixteen. twitter will start allowing its users to charge their followers for access to additional content. the social media site says its also considering subscription charges to use its tweetdeck platform and making advanced analytical data available only to influenc

of 50 and test the effectiveness of 4 combinations of 1st and 2nd shots of the astra zeneca oxford university vaccine and the pfizer biotech vaccine results of the trials are not actually expected until june or july on thursday u.k. minister for coping 19 vaccine deployment that he was how we promised this would not affect the current vaccine rollout and spoke about the work done to make sure vaccines would protect against the roughly $4000.00 variants of the virus all managed matches by an attacker but done a cool spot should cost money and dollars are looking at how we can improve them actually to make sure that we are ready for any veteran ramos out of batteries round are well over now and with tb and library of all the very ones we're ready to be able to respond more than the will to all be on any kind of bothers me present and produce next baxley. so with this in mind let's take a look at the state of the vaccine rollout as well as the trends and spread of the virus with r.t. correspondent science having her silent where are we thursday sybren here in the us as since the accident should

1000 vaccines for the 1st and 2nd doses will show strong efficacy the trials will be led by oxford university and run by the national immunization schedule of valuation consortium now the 1st trials that will involve more than $800.00 volunteers above the age of 50 and test effectiveness of 4 combinations of 1st and 2nd shots of the astra zeneca oxford university vaccine and the fires are biotech vaccine results of the trials are not actually expected until june or july on thursday u.k. minister for coping 1000 vaccine deployment that. the how we promised this would not affect the current vaccine rollout and spoke about the work done to make sure vaccines would protect against the roughly $4000.00 variants of the virus all monies that she has a biotech. and dollars are looking at how the. vaccine to make sure that we are ready and a very robust force 1000 barriers around well. now and will keep me alive all the bearings we're ready to be able to. all be on. charlie bars me and. so with this in mind let's take a look at the state of the vaccine rollout as well as the trends and spread of the v

astrazeneca and oxford university say they plan to have a next—generation covid vaccine ready for theorts. the scientists at oxford who created the astrazeneca vaccine are continually monitoring how coronavirus is evolving. the current vaccine is thought to give good protection against new variants, but they're working on tweaking the jab to make it future—proof. the scientist who's leading the research says it's relatively simple to redesign the vaccine. it's not difficult to put a different antigenic insert into the vaccine. so, we don't want to panic and say that we must have a new version of the vaccine now but on the other hand we are getting prepared, so that if it turns out we do need a new version, we will be ready to start using it. it'sjust going to be a sharp scratch, 0k? those on the oxford vaccine trials were shown to have 76% protection from a single dose, which lasted three months, rising to 82% protection, with the second shot. you'll be doing swabs every week at home. it's also the first time a covid vaccine has been shown to reduce transmission of coronavirus. those

comfort or a decade of action and that in i think the fear of the jobs come from 2 sources the oxford university astra zeneca cova shield vaccine and kovacs it which is developed by the indian pharmaceutical company bharat biotech now pennsylvania based oxygen inc wants to bring kovacs into the states the biopharmaceutical company which traditionally deals with fighting blindness has entered an agreement with india's bharat biotech oxygen tweeted we are excited to announce the definitive agreement for the commercialization of kovacs in the us with bharat biotech and share in the us commercialization profits kovacs and received emergency use authorization approval in india in january according to a press release from oxygen the company plans to receive an initial supply of kovacs and doses from bharat biotech once the vaccine is approved by u.s. regulatory authorities in the meantime it will ramp up its own manufacturing process of the vaccine in the us while the vaccine is already being used in india due to the emergency use authorization it is simultaneously in its phase 3 of clinical trials in

we'll also have details of a new vaccine developed by astrazeneca and oxford university, due for releaseautumn. also tonight... in portugal, hospitals are struggling, and in recent days they've seen some of the world's highest rates of new infections. in myanmar, a second day of protests following the military coup which removed the country's elected leaders. we report on the pandemic�*s effects on children's mental health, with many dealing with grief or loneliness. it feels like we're all alone in the world because you can't talk... you can talk to somebody but you can't tell them what you really feel. applause. and the nationwide applause for captain sirtom, as his family leads tributes to the man who raised millions for the nhs. and coming up in sport on bbc news... manchester city re—establish a three point lead at the top of the premier league, as raheem sterling scores in their 2—0 win over burnley at turf moor. good evening. more than 10 million people across the uk have now received at least one vaccination for coronavirus as part of the biggest programme of its kind in the hist

there has been no comment from astrazeneca or oxford university on this study but crucially, it's beenive in preventing deaths in hospital admissions. yesterday the head of astrazeneca said it wouldn't be surprising if levels of protection dip with the south african variant given what we have seen in early results from other vaccines. developers are working on tweaking their vaccines to cope with emerging variance. it is something that already happens with the flu jab and it could be in future that we need to have a booster shot each year. this that we need to have a booster shot each year.— shot each year. as the global race to produce _ shot each year. as the global race to produce and - shot each year. as the global| race to produce and distribute covid—i9 vaccines continues, china appears to have made huge strides. sinovac and sinopharm are already making their way abroad. speight cautioned that the data range for people aged 16 and above is limited, their i6 and above is limited, their drugs have received approval. from mask diplomacy to vaccine diplomacy. china has been working h

senior clinical research at the trial in oxford at oxford university she says the trial is of crucial importance. we have certain rights given to terraces of the same vaccines that the m.r. kneedler scenes or the book said byron back to back scenes are safe and to active but we want to look at is whether giving different back scenes here her 1st and 2nd work just as well using different types of scenes has been used in typical trials before and we haven't used them are in a backseat with other sorts of vaccines in the past and what we're wanting to do is seeing whether these approved vaccines can be used safely and effectively in combination schedules the flexibility of using 2 different vaccines means that on an individual level level it will be much simpler to deliver a vaccine. to a 2 to one person so if you turn up at your g.p. surgery you have one vaccine and then you come back to have a 2nd vaccine a bit later if that's a different vaccine that's not a problem but we need to have to gather the data to show that and that also works on a on a why disco era nationally and globally

. >>> coming up, setback for astrazeneca oxford university vaccine in south africa. details next >>> welcome back to "street signs," everybody. the astrazeneca/oxford university vaccine is good against the covid-19 the vaccine had similar efficacy against the variant first found in september south africa has stopped the new rollout after a new study found it offers minimal protection against the new strain of covid-19 variant there there's a look at european pharma more broadly. stocks are trading more in line with pharma. coming back to the data released over the weekend, in particular yesterday's preprint study from university of oxford, the key takeaway from this release is that the vaccine is proven to be just minimally effective in preventing mild to moderate covid-19 in the south african study, but the study was not able to determine whether the vaccine is effective against preventing severe covid. the study was based on 2,000 participants average age 31 years old. but for me, the key message here is the rhetoric within the release that scientists are optimisti

and there's another issue the astra zeneca oxford university vaccine accounts for almost all the doses that the kovacs program wants to start distributing later this month but south africa is delaying the rollout over concerns that the drug may not be effective against the new variant which 1st emerged there. to end up with a situation that in a certain 1000000 people or 2000000 people that seem to me not be effective in preventing hospitalization and severe disease other countries are now stepping in china has only recently joined kovacs it's now offering the program 10000000 doses but beijing has already sold all donated large quantities of its 3 vaccines to countries around the world. 50000000 doses are being bought by turkey alone. and moscow to profess to do its own deals. iran just the latest to get russia's sputnik the vaccine. the kovacs program still hopes to deliver more than $2000000000.00 vaccines by the end of the year scientists warn if that fails the world will pay the price it's not about $1.00 country versus another it's about one world protecting. extreme freezing wea

>> reporter: rosemary, i can tell you that this news from oxford university and astrazeneca about theited effectiveness against the south african strain is concerning. this country is prepared to deal with any variants of covid-19. how are they dealing with that? they have a genomic sequencing program and they're making new vaccines if they need to. that's not all, you may have to have an annual shot to deal with any new mutations. >> we see very much probably an annual or a booster in the autumn and an annual with the way we do with flu vaccines. you look at what variant is spreading and you rapidly produce it and begin to vaccinate and protect the nation. >> reporter: so future plans being made for future variants. the sense that very much this is a virus that's going to stick with us, rosemary, even if we get out of this pandemic and this difficulty. this is a virus that will live amongst the population. in the meanwhile, vaccinate as many people as possible. try to immunize yourself out of lockdown. it really is a race against time as you said, rosemary. >> certainly is. thank you

oxford astra zeneca shot could indeed prevent people from spreading covert 19 the research by oxford university is the 1st to show a vaccine stopping the corona virus being passed on as well as protecting against the illness the university says the back seam could cut transmission of the virus by 2 thirds scientists also found that a single shot can offer a high level of protection for up to 12 weeks more than 10000000 britons have already been vaccinated british health minister matt hancock had this to say about the new study at this. report is a very good news at 8 backs the strategy that we've taken and it shows the world that the oxford vaccine works effectively and the really good news embedded in it is that it not just reduces hospitalizations that we know people in this part of the trial who hospitalized. do with covais that after getting the ox jab but also it reduces the number of people who have actually even asymptomatic by around 2 thirds. comments from the british health minister there well earlier we spoke to paul or hunter he's a professor of medicine at the university of east an

nations are accused of using it as an added extra and there's another issue the astra zeneca oxford university vaccine accounts for almost all the doses that the kovacs program wants to start distributing later this month but south africa is delaying the rollout over concerns that the drug may not be effective against the new variant which 1st emerged there. the situation is actually newton 1000000 people or 2000000 people seeing that may not be effective in preventing hospitalization and so the disease other countries are now stepping in china has only recently joined kovacs it's now offering the program 10000000 doses but beijing has already sold all donated large quantities of its 3 vaccines to countries around the world. 50000000 doses of being bought by turkey alone. and moscow to prefers to do its own deals. iran just the latest to get russia's sputnik v vaccine. fax program still hopes to deliver more than $2000000000.00 vaccines by the end of the year scientists warn if that fails the world will pay the price it's not about $1.00 country versus another it's about one. protected. joinin

variants britain is one of many countries that has bought large amounts off of r c developed by oxford university and astra zeneca. at the weekend south africa suspended plans to launch a mass vaccination program using that vaccine study showed that even though it largely prevents the illness from getting serious it offered less protection against mild to moderate illness caused by the virus variant that originated in south africa to the abuse everyone creech reports from that. it was supposed to be the turning point in south africa's fight against corporate 19 the arrival of 1000000 doses of the astra zeneca havoc seen last week presidents who run up was and the health minister came to receive it personally but the doses will remain in storage for now and you study suggests the vaccine appears to offer only minimal protection against mild and moderate disease from the new variants that was discovered in south africa the government's roll out plan is now on hold. if we want to send is a risk what do we do with a citizen you can. just dream. it is watching what. we do upward so there is no potenti

trial was led by oxford university is a professor mona buffet all who was cold so coauthored a study welcome to day w this sounds like a big step forward given that aspirin medication is widely available and inexpensive. yes i mean it was. quite fascinating that the study was suggestive of a positive outcome with this inhaled medicines. and we are quite. pleased with that but obviously with the understanding that it was a small limited study and so last results would be suggestive of that and we look forward to hearing from. investigators who are also looking in similar fashion similar medicines ok so as a small study we were able to identify what it was about v.a.'s ozma medications that makes them so effective against common symptoms it's so studies already in the process so early on in the pandemic and from last year showed that in the bowl that tree the asked my inhale medicines could reduce virus replication in the lung knighting so but this is experimental studies and our findings that actually chronic illnesses with respect she mentioned such as asner and chronic struck to bec

that the oxford astra zeneca shot couldn't be prevent people from spreading 19 the research by oxford university is the 1st to show a vaccine stopping the corona virus being passed on as well as protecting against you know university says the vaccine could cut transmission of the virus by 2 thirds scientists also found that a single shot can offer a high level of protection for up to 12 weeks more than 10000000 britons have already been vaccinated. the british health minister matt hancock had this to say about the new findings at this. report is a very good news at 8 'd backs the strategy that we've taken and shows the well the often vaccine works effectively and the really good news embedded in it is that it milt just reduces hospitalizations that we know people in this part of the trial who hospitalized. do we kind of add up to getting the job but also it reduces the number of people who have actual even a symptomatically by around 2 thirds well the technology being used in that vaccine from another vaccine for biotech pfizer and others also promises to become powerful new weapon in the fight

a new study from oxford university showing astrazeneca vaccine not only protects people from getting sick but from spreading. not yet peer reviewed. a vaccine reducing transmission by 67% it was also shown to be 76% effective at preventing disease after just one dose. it could be authorized for use in the u.s >> we have an impact on infection and transmission >> reporter: it comes amid growing concerns over new variants over taking the u.s. this 35-year-old father of two in alabama is one of the first known death from the u.k. mutant strain which researchers believe it is up to 40% infectious >> if they become dominant, we need to upgrade the vaccine, that's the direction we are going right now. >> reporter: the biden administration announced the new federal state partnership launching two mass vaccination sites in california, the first of 100th nationwide, it is aimed at closing the gap at vaccine access in under served communities. >> this is an equity driven community based partnership. >> reporter: in east oakland where they'll vaccinate at the coliseum the disparity in the natio

reports out of france, sweden, austria of local groups asking for the moderna vaccine over the oxford universityrazeneca vaccine. there is a difference in every case. oxford and astrazeneca is around about 63% effective. the moderna vaccine around 95% effective according to the figures. but of course all of these doses have to be used. i can give you an example just here in london, i witnessed the on which si on that it of that where people were asking for ox ford vaccine because of national pride that it was developed here in the uk. and in these vaccinationit of t were asking for ox ford vaccine because of national pride that it was developed here in the uk. and in these vaccination centers, you have to explain your medical history, you have to explain any symptoms that you might be having and now you might have to explain the efficacy. i was at one where the primary language wasn't even in english, so imagine having to do that in multiple languages. it is a complicated picture and it will only raise that vaccine hesitancy concern around the xw globe. >> crazy to hear people talking about it a

well essentially the oxford university astra zeneca team are confirming what the researchers in south africa are saying according to preliminary data oxford university ses the still needs to be peer reviewed the full details to come in the coming days yes indeed the oxford asked astra zeneca vaccine is minimally effective against people with mild forms of the virus what oxford have confirmed is though that the research did not assess people with serious infection serious strains of the 19 south african strain but the hope is given that the research carried out in south africa suggests that they could still be an impact on reducing the number of people needing serious treatment or ending up in hospital it still has a degree of effectiveness and still should be administered there is a right of light here in the message from the oxford team is that the existing vaccines could indeed be tweaked and very quickly without the need for a large clinical trial afterwards it appears and we've known this for some time that they take over 19 virus will mutate that is an inevitable so the challenge

forward whether source started let's bring in a merely a scam and viral or just at the ukase university of oxford him earlier thanks for your time today so an escape from the lab theory was always making the rounds as well as the wet market looks like the labs off the hook how important is it anyway to find out exactly where this whole mess started and what are going to make any difference now anyway it is important so we can see where really these by. what is their natural reservoir so we can prevent future pandemic. and we will be hopefully more successful than with this one so it is important obviously it will be very hard right now because a lot of time passed since since the beginning but keep cropping up here they seem to be a reservoir for this kind of thing dug way. yes yes of course and bad as it were couldn't have. and we know that we knew that for a long time so that starts the most probable source of. discord innovators why is it so hard to pin down the origin of what happened to you said just now while it's you know a long time has passed or that bearing in mind should the show me go

study conducted by south african university and oxford university which helped develop astrazeneca's vaccine. it has reduced efficacy against that strain, no one who has received it has been hospitalized or died. astrazeneca vaccine has not yet been authorized for use in the united states. >>> learning new details of how a woman from california got a personal call from president joe biden. 47-year-old michelle featured in a short video the white house released today, the president calling her to talk about a letter urging him not to forget those struggling financially because of covid-19. she lost her job at san francisco-based company in july. volker told us she wrote the letter to serve as example to her daughter. >> my daughter had watched things happen at capitol and wanted to demonstrate to her writing a letter would be more impactful than breaking windows. somehow or another it worked. >> the short conversation was focused on how the loss of a job can mean so much more than the loss of paycheck. also talked about vaccines. and her daughter was able to say hi to the president as

because this astrazeneca oxford university vaccine has not been approved by fda but the u.s.act the vaccine rollout there. what they found in south africa in this trial is that with the south african variant, as it's called, the astrazeneca vaccine has a mild impact on massive disease, attacks substantial disease but mild disease not so much. which tackles infections, we've been speaking to a researcher at oxford university who says they're racing to adapt their vaccine. >> i think we should be concerned about the variants but certainly not panic. our research program, like those of many vaccine developers around the world, is now focused on these variants, asking the question, can we develop vaccines specific to those variants very quickly? how much difference would that make? how long would it take? and that's something that needs to go forward very rapidly. >> now to be clear, steph, the evidence is that other vaccines like the pfizer vaccine, johnson & johnson are still able to prevent infection, and tackle mild disease, even in the south african variant, even, for exampl

at the same time a new study shows the shot developed by the drug from astra zeneca and oxford university remains highly effective for 3 months after a single dose. i'm captain so tell me more the 100 year old veteran who raised millions of pounds for british health workers during knock down has died your chief aim of to setting himself a target to walk laps of his garden ended up with a total of $43000000.00 so tom was taken to hospital with pneumonia and had tested positive for corona virus britain's prime minister has described him as a hero in the truest sense of the word. there's a top stories do stay with us out as their world continues next idea. for. the sultanate of our mind has a rich history and was once the dominant power in the whole gulf region it had a powerful navy and colonized large areas of east africa in the 17th and 18th centuries. the alba sided dynasty came to power in 749 and the same family still rules online today in 1806 sorry had been sold on a booze idea took power. but by the early 18 hundreds other tribes like the on the northern coast had their own separati

at the same time a new study shows the shot developed by the drug for astra zeneca and oxford university remains highly effective for 3 months after a single dose. and captain so told more the 100 year old veteran who raised millions of pounds for british health workers during lockdowns has died here chief a martyr setting yourself a target to walk laps of his garden he ended up with a total of $43000000.00 tom was taken to hospital with pneumonia and had tested positive for corona virus was the top stories do stay with us the fans who make football is up next more news after that of the 1st and if you don't i will. tell you when you. 'd get. to what you. can you do enough. to learn on your behalf you. can even. through it. was. that. there are that. i. the magaluf are a stay at home to slay man for all i. hear on these terraces a revolution is happening it's impacting not only football but also indonesian society. we're seeing the rise of a pioneering group of female ultra fans and they're taking age by storm i. internees this country has the largest muslim population in the world. yogy

new research from oxford university suggests the protection provided by the first dose of the oxfordeek of the 15th of february, we will be accumulating even more data, helped by nhs test and trace, so that we can begin to chart a way ahead, starting, if the data allows, with the reopening of schools on march 8th, and i'll be setting out as much as we can about that road map forward on february the 22nd. and though today there are some signs of hope, the numbers of covid patients in hospital are beginning to fall for the first time since the onset of this new wave, the level of infection is still alarmingly high, and i am sorry to say that we have lost another 1322 lives in the last 24 hours alone, and our hearts again go out to every family that grieve. and the wards of our nhs are under huge pressure, with more than 32,000 covid patients still in hospital. and so tonight let's clap together for captain tom at 6pm, and let's clap for the spirit of optimism that he stood for, but let's also clap for all those he campaigned for, our brilliant nhs staff and care workers, and let's do e

new research from oxford university suggests the protection provided by the first dose of the oxfordzeneca vaccine kicks in after three weeks and lasts right the way through to the booster at three months. and research also shows that the oxford astrazeneca vaccine seems likely to reduce transmission to others. the prime minister went on to say that while today's news was hugely positive, more data is required before considering any relaxation of the covid restrictions. nonetheless, the uk government will take great satisfaction in those numbers. per capita, israel still leads the way in vaccinating its citizens, but the uk and us are now making significant progress. remember — at least 70% of the population in a country has to be vaccinated before we can think about reaching herd immuninty. —— herd immunity. in the us, the cases and hospitalisations continue to fall, though the head of the cdc said today the spread of the variants remains a cause for concern. not wearing masks and participating in in person social gatherings have contributed to the variants' spread. we must take pre

we have in day we've heard from astra zeneca and researchers oxford university and the both of them of course of have to concede that their vaccine isn't as effective as hoped against the south africa strain astra zeneca saying that its scope was limited oxford research is saying that its service spawns was minimal to maal to moderate infections of the south africa strain what we don't know really because no research has yet been done in full is the impact on serious infections of south africa strain but the shared opinion formed leading scientists in south africa and here in the u.k. is a hopeful one but it could indeed still prevent the worst effects of that strain preventing people from ending up in hospital and also preventing people from of course dying off this serious as well which is the message that johnson the british prime minister has been very keen to hit home i think largely over fears that this news in some way undermines britain's very very successful vaccine rollout today we know that more than 12000000 people have had at least one dose of a vaccine the hope is that by

he's also a gp and professor of primary care at oxford university. relief. it they are safe i suppose. -- a sigh of relief. , ., , of relief. it is great news. the ublic of relief. it is great news. the public want — of relief. it is great news. the public want to _ of relief. it is great news. the public want to be _ of relief. it is great news. the public want to be sure - of relief. it is great news. the public want to be sure that. of relief. it is great news. the | public want to be sure that our records rebutted the mhr a are world—class and are looking at the safety data on a daily basis, the jcb |, —— thejcpoa safety data on a daily basis, the jcb i, —— thejcpoa are also looking at these, and we have seen no safety signals from either of these vaccines which is good news because of course trials have been in lots of course trials have been in lots of people, tens of thousands of people and that can be very different than when you grow out a vaccine to millions of people. and the fact we see no safety signals that are serious is very reassurin

as yung as -- young as 6 to 12 years old are enroll in a small trial through oxford university. pfizer, moderna and johnson & johnson are expected to start trials in the spring. >> parents have concerns about getting their kids vaccinated against everything, and this is i think a much more heavily studied -- it uses new technology, which should be safer. >> ewathey want to know when they're going to get them. >> dr. lisa dana said parents and patients are asking for the vaccinations already. >> i do not think they will be released until they're safe and i trust they'll be safe when available. >> reporter: not all parents are convinced. >> to me i believe they came up with this method too soon. i'm not a believer. >> reporter: while immunizing may be important for her immunity, it should not be a prerequisite to return to the classroom. >> i think we do not need to wait for kids to be immunized to get them back to school. >>> congressional leaders say they're committed to confronting and ending attacks on the asian-american community. the asian-american caucus held an open forum

scientists at oxford university and astrazeneca say they're working on the next generation of covid vaccinesthat theirjab can be adapted to work against different strains of the virus. the virus is already mutating, first here in the uk, then in brazil and south africa. hospitals in portugal are struggling to cope with a sharp rise in coronavirus cases. nearly half of the country's 13,000 covid fidelity is occurred just last month. it has been a worrying time for a country that had been doing better than its european neighbours battling the outbreak —— fidelity�*s. germany has sent help. now on bbc news it's hardtalk with stephen sackur. welcome to hardtalk, i'm stephen sackur. alexander lukashenko still sits in the presidential palace in belarus, six months after an election which he probably lost. europe's last de facto dictator continues to brutally repress protests and imprison political opponents. my guest is sviatlana tsikhanouskaya, the woman who believes she won last august's vote, and who, from exile, calls herself the leader of democratic belarus. but is toppling lukashenko any clo

organization has granted an emergency authorization to the coronavirus vaccine made by astrazeneca and oxford universityve should allow astrazeneca's partners to ship millions of doses to countries taking part in the u n backed program to tame the pandemic the astrazeneca vaccine was approved for emergency use in the united kingdom at the end of december but that vaccine has not yet been approved for use here in the united states. and in response to all the new variants the makers of covid-19 vaccines are making changes to guard against them health officials say many of the new covid-19 vaccines. >>aid was new flexible technology. that's easy to upgrade, but the challenge is deciding. if the virus has mutated enough that it's time to modify vaccines and what changes to make. they're looking at the global flu vaccine system and using that as a guide to handle similar decisions about covid vaccines. now it's time to talk about our weather kron 4 is a chief meteorologist lawrence karnow joins us now with a look ahead at the rest of the lords. >>we saw some rain earlier today any more on the way yeah we may

company, astrazeneca, says a small trial suggests the coronavirus vaccine it's developed with oxford universitydoes not appear to offer much protection against mild or moderate disease, caused by the south africa variant. but the firm believes the jab would protect against severe disease. thousands of indian farmers brought some of the country's major roads to a standstill to show their opposition to new agriculture reforms, that they say would leave them out of pocket. dozens were arrested with more than 50,000 members of the security services being deployed for the protests. a leaked document has revealed that borisjohnson is considering a reform of the nhs in england. the changes could see a reduced role for the private sector and sweep away changes introduced by david cameron's government in 2012. nhs commissioners would no longer be required to invite private companies to bid to run services and there would be more focus on hospitals and social care services working together to improve patient care. our health correspondent katharine de costa reports. an ageing population brings with it th

scientists at oxford university and astrazeneca say they are working in the next generation of covidaccines so it can adapt to different strains of the virus. different variations have been found in the uk, brazil and south africa. in portugal, hospitals are struggling, as the country suffers some of the world's highest rates of new covid infections. it isa it is a worrying turn of events for a country that had been doing better than its neighbours in europe regarding the outbreak. as we've been hearing, more than 10 million people have now received their first dose of a coronavirus vaccine, with an army of volunteers giving up their time to help with this massive effort. we spent the day at a vaccine centre in southall in west london with a gp, dr kamini gautam, who takes up the story. this is the dominion centre. this is where patients come to get vaccinated in southall. this is the main hall. patients will enter through the door that says "no exit" over the top of it, because it's a one—way flow. they will be directed by our lovely stewards. we've vaccinated over 11,000 people her

well and speak to the infectious disease and global health expert peter draw back from oxford university here in the u.k. thank you so much for joining us here on al-jazeera once again so 1st of all what do you make of boris johnson's at plans to reopen the country and crucially of course the timing of the various phases. barbara thank you for having me over oh i was really pleased by the announcements today i think that you know they've got their priorities right focusing on getting kids back into school 1st and lower risk outdoor activities and this very phased slow and flexible approach that's based on as they said data not dates i think is the right way to go having about 5 weeks at least between each stage would allow us to kind of assess what kind of effect that easing of certain restrictions could then have on infection rates and of course we do expect as we ease up on things there is a risk that things are going to go up so too to a great extent i'm very pleased you know i have to say that i would prefer that the reopening of schools be a bit more phased i think opening all schoo